Skip to content

Addiction: all studies

Page 258 of 855: studies 2,571 to 2,580 of 8,547, newest first. Back to the addiction overview

Research

Inclusivity in global research questionnaire.

Figshare October 13, 2025 Francisco González Espejito (22421436), Laura Esteban Rodríguez (16363059), Eduardo J. Pedrero Pérez (22421439) et al.

Ibogaine, an indole alkaloid derived from the root bark of Tabernanthe iboga, has long been used in traditional Bwiti healing rituals and shows promise for treating opioid dependence and neurological conditions, but existing psychometric tools fail to capture its distinctive subjective/oneiric (dream-like) effects. To address this gap, we developed the 70-item Ibogaine Experience Scale (IES)...

DOI: 10.1371/journal.pone.0333296.s007 (opens in new tab) Introspection Exploratory factor analysis Qualitative research Internal consistency +13

Items comprising each factor and factor names.

Figshare October 13, 2025 Francisco González Espejito (22421436), Laura Esteban Rodríguez (16363059), Eduardo J. Pedrero Pérez (22421439) et al.

Ibogaine, an indole alkaloid derived from the root bark of Tabernanthe iboga, has long been used in traditional Bwiti healing rituals and shows promise for treating opioid dependence and neurological conditions, but existing psychometric tools fail to capture its distinctive subjective/oneiric (dream-like) effects. To address this gap, we developed the 70-item Ibogaine Experience Scale (IES)...

DOI: 10.1371/journal.pone.0333296.s003 (opens in new tab) Exploratory factor analysis Psychometrics Internal consistency Introspection +9

The Ibogaine Experience Scale (IES): Development and psychometric properties of a multidimensional measure of ibogaine’s subjective effects

PLoS One October 13, 2025 Francisco González-espejito, Laura Esteban Rodríguez, Eduardo J. Pedrero Pérez et al.

Ibogaine, an indole alkaloid derived from the root bark of Tabernanthe iboga, has long been used in traditional Bwiti healing rituals and shows promise for treating opioid dependence and neurological conditions, but existing psychometric tools fail to capture its distinctive subjective/oneiric (dream-like) effects. To address this gap, we developed the 70-item Ibogaine Experience Scale (IES)...

DOI: 10.1371/journal.pone.0333296 (opens in new tab) Psychometrics Exploratory factor analysis Scale ratio Internal consistency +6

Ibogaine Experience Scale (IES).

Figshare October 13, 2025

Ibogaine, an indole alkaloid derived from the root bark of Tabernanthe iboga, has long been used in traditional Bwiti healing rituals and shows promise for treating opioid dependence and neurological conditions, but existing psychometric tools fail to capture its distinctive subjective/oneiric (dream-like) effects. To address this gap, we developed the 70-item Ibogaine Experience Scale (IES)...

Psychedelic 5-HT2A receptor agonism alters neurovascular coupling and differentially affects neuronal and hemodynamic measures of brain function

Nature Neuroscience October 13, 2025 Jonah A. Padawer-Curry, Oliver J. Krentzman, Chao‐cheng Kuo et al. 9 citations

Human neuroimaging studies report that psychedelics induce serotonin-2A receptor-dependent changes in functional brain reorganization, presumably reflecting neuromodulation. However, these studies often overlook the potent vasoactive effects of serotonin. Here we identified psilocybin-induced alterations in hemodynamic response functions during human functional magnetic resonance imaging,...

DOI: 10.1038/s41593-025-02069-z (opens in new tab) Full text (opens in new tab) Premovement neuronal activity Hemodynamics Neuroimaging Haemodynamic response +7

Mindfulness and problematic smartphone use: indirect and conditional associations via self-regulated learning and digital detox.

BMC Psychology October 10, 2025 Aamer Aldbyani, Zhang Chuanxia, Afnan Alhimaidi et al.

Previous research indicates that mindfulness is associated with lower levels of addictive behaviors, including problematic smartphone use. However, the mechanisms underlying this relationship remain insufficiently explored. Self-regulated learning has been identified as a process that may partially account for this association, while digital detox practices may be associated with stronger...

Psychedelics in Practice: Science, Safety, and the Future of Healing

PROCEEDINGS OF THE SLIIT INTERNATIONAL CONFERENCE ON ADVANCEMENTS IN SCIENCES AND HUMANITIES [SICASH] October 10, 2025 Renee Ireland

Psychedelic-assisted therapies are re-emerging as credible options in psychological care amid a high global burden of mental ill-health and limited response to first-line treatments. Once marginal, psychedelics are now part of mainstream research and policy debate, while remaining illegal or tightly restricted in many jurisdictions. Classic and atypical compounds (e.g., psilocybin, MDMA) act...

The translational potential of salvinorin A: systematic review and meta-analysis of preclinical studies.

Translational Psychiatry October 10, 2025 Wolfgang Emanuel Zürrer, Lionel Wettstein, Helena Aicher et al. 3 citations

Salvinorin A, the main psychoactive compound of Salvia divinorum, is a potent and selective kappa opioid receptor agonist. While human clinical trials remain limited, animal studies suggest potential therapeutic applications in neurological and psychiatric disorders. This systematic review and meta-analysis aims to synthesize these preclinical findings, addressing three questions: (1) What is...

The translational potential of salvinorin A: systematic review and meta-analysis of preclinical studies

Universität Zürich, ZORA October 10, 2025 Wolfgang Emanuel Zürrer, Lionel Wettstein, Helena Aicher et al.

Background: Salvinorin A, the main psychoactive compound of Salvia divinorum, is a potent and selective kappa opioid receptor agonist. While human clinical trials remain limited, animal studies suggest potential therapeutic applications in neurological and psychiatric disorders. This systematic review and meta-analysis aims to synthesize these preclinical findings, addressing three questions:...

DOI: 10.5167/uzh-282729 (opens in new tab) Pharmacology Κ-opioid receptor Antidepressant Clinical trial +7

Psilocybin’s effect on human brain synaptic plasticity

Research Square October 10, 2025 Gitte M. Knudsen, Annette Johansen, Pontus Plavén-sigray et al. preprint

Abstract Psychedelics such as psilocybin have been linked to enhanced neuroplasticity and symptom relief in affective disorders, but the neurobiological mechanisms and impact of environmen-tal context remain unclear. Here, we tested whether a single dose of psilocybin alters synap-tic density in healthy individuals and whether setting-dependent subjective experience shapes this effect. Fifteen...